| Revenue growth | 26% YoY consolidated income growth in Q1 FY27. |
|---|---|
| Margins | Consolidated margins at 23.8%; Cluster 1 at 24.1%; Cluster 2 at 32% (ex-Noida). |
| Order book | Pipeline of nearly 3,350 additional beds under development. |
| Demand visibility | Strong 'flight to quality' tailwinds in Central and Northern India. |
| Management confidence | High; stating Noida is ahead of internal financial return expectations. |
Growth
Revenue grew 26% YoY. Reported EBITDA rose 23% to INR 3,153 million with 23.8% margins. Inpatient volumes increased 28%.
Outlook
Planned expansion to 3,350 additional beds; Guwahati hospital upscaled to 650 beds with INR 9,700 million capex.
Risks
Higher depreciation and finance costs from asset expansion; high nursing and junior doctor attrition rates common to industry.
Last quarter's promises, checked
Delivered
- Guided Noida breakeven in H2 FY27 → delivered ahead of expectations in Q1 FY27 (= BEAT)
- Guided 500 bed additions in short-term → delivered 623 beds in FY26 (= BEAT)
- Guided 24-25% mature unit margins → delivered 26.7% in Q4 FY26 (= BEAT)
Partly delivered
- Guided 400-bed Guwahati hospital → delivered upscaled target of 650 beds (= PARTIAL)
Investor Presentation filed with BSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,495.40
- Market cap
- ₹40,208 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 72.3×Sector 57.8×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Earnings Call Transcript: Key Takeaways
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health Investor Presentation: Key Takeaways
Global Health (Medanta) reported 26.2% YoY revenue growth in Q1 FY27, driven by strong patient volumes and narrowing losses at the Noida facility.
Global Health Q1 FY27 Results: Net Profit ₹157.3 Cr, Down 1.1% YoY
Global Health Ltd reported revenue from operations of ₹1,304 Cr (+26.5% YoY) and net profit of ₹157.3 Cr (-1.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹157.3 Cr · -1.1% YoY